InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（5 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
5
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Sandison Taylor. Director active across 1 company, notably Cidara Therapeutics, Inc.. Cumulatively, 10 filings have been published. Split: 0 buy · 5 sells. Total volume traded: €62k. History available since 30 September 2021. The latest transaction was filed on 11 September 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Sandison Taylor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
924 股@ US$11.636715.8% 占其流量Common StockSEC:0001610618-24-000125:0
128,750 股0Common StockSEC:0001610618-24-000024:0
20,662 股@ US$0.669820.5% 占其流量Common StockSEC:0001610618-24-000013:0
18,793 股@ US$0.947726.8% 占其流量Common StockSEC:0001610618-23-000088:0
90,000 股0Common StockSEC:0001610618-23-000032:0
7,203 股@ US$1.5316.7% 占其流量Common StockSEC:0001610618-23-000010:0
18,478 股@ US$0.684920.2% 占其流量Common StockSEC:0001610618-22-000079:0
50,000 股0Common StockSEC:0001610618-22-000027:0
15,600 股0Common StockSEC:0001209191-22-002601:0
150,600 股0Common StockSEC:0001610618-21-000093:0
10 条申报中的 10 条
About Sandison Taylor
Sandison Taylor is Chief Medical Officer at Cidara Therapeutics, Inc. The 10 filings recorded are all sales, and within the 10 sampled filings, the sales total EUR 61788 between 2021-10-04 and 2024-09-13.
